Fibulin 5 anticorps (C-Term)

N° du produit ABIN966131

Il existe 2+ publications pour ce produit. L’anticorps anti-Fibulin 5 Polyclonal Lapin est utilisé pour la détection de Fibulin 5 dans des échantillons de Humain, Souris et Rat. Il a été validé pour IHC.

Aperçu rapide pour Fibulin 5 anticorps (C-Term) (ABIN966131)

Antigène: Fibulin 5 (FBLN5)

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Fibulin 5 est non-conjugé

Application: Immunohistochemistry (IHC)

Détail du produit anti-Fibulin 5 anticorps

Épitope: C-Term

Purification: Purified by antigen-specific affinity chromatography.

Immunogène: Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to C-terminal residues of human FBLN5 (Fibulin-5 precursor)

Information d'application

Indications d'application: ELISA, Western blotting: 1µg/ml for 2hrs.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: This antibody is stored in PBS, 50% glycerol

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Références pour anticorps anti-Fibulin 5 (ABIN966131)

Stone, Braun, Russell, Kuehn, Lotery, Moore, Eastman, Casavant, Sheffield: "Missense variations in the fibulin 5 gene and age-related macular degeneration." dans: The New England journal of medicine, Vol. 351, Issue 4, pp. 346-53, (2004) (PubMed).

Nakamura, Ruiz-Lozano, Lindner, Yabe, Taniwaki, Furukawa, Kobuke, Tashiro, Lu, Andon, Schaub, Matsumori, Sasayama, Chien, Honjo: "DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries." dans: The Journal of biological chemistry, Vol. 274, Issue 32, pp. 22476-83, (1999) (PubMed).

Détails sur Fibulin 5

Antigène: Fibulin 5 (FBLN5)

Autre désignation: FBLN5

Sujet: FBLN5(Fibulin-5) promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It could be a vascular ligand for integrin receptors and may play a role in vascular development and remodeling. FBLN5 (Fibulin-5) is expressed predominantly in heart, ovary, and colon but also in kidney, pancreas, testis, lung and placenta. Not detectable in brain, liver, thymus, prostate, or peripheral blood leukocytes.

Pathways: SARS-CoV-2 Protein Interactome